Sanjay Rajanikant Mehta
Direttore/Membro del Consiglio presso Zuventus Healthcare Ltd.
Patrimonio netto: 158 $ in data 30/09/2021
Profilo
Sanjay Rajanikant Mehta is currently a Non-Executive Director at Zuventus Healthcare Ltd.
and President-Emerging Markets at Emcure Pharmaceuticals Ltd.
He completed his undergraduate degree at the University of Pune.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
Emcure Pharmaceuticals Ltd.
 Emcure Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Emcure Pharmaceuticals Ltd. engages in developing, manufacturing and marketing of pharmaceutical products. Its products include Nucron, Xennea, Xennex, Nifirex, Criante and Oncocare. The company offers calcium channel blockers, beta blockers, hypotensive combinations, statins, anti-coagulants, and diuretic combinations for cardiology. Its product portfolio includes orals, injectable and biologics, as well as an mRNA platform through which it is developing a COVID-19 vaccine. The company was founded by Satish Ramanlal Mehta on April 16, 1981 and is headquartered in Pune, India. 8.72% | 18/08/2021 | 15 764 028 ( 8.72% ) | 158 $ | 30/09/2021 |
Posizioni attive di Sanjay Rajanikant Mehta
| Società | Posizione | Inizio |
|---|---|---|
Zuventus Healthcare Ltd.
 Zuventus Healthcare Ltd. Pharmaceuticals: MajorHealth Technology Zuventus Healthcare Ltd operates as pharmaceutical company. The company was founded in 15th July, 2002 and is headquartered in Mumbai, India. | Direttore/Membro del Consiglio | 11/05/2011 |
Emcure Pharmaceuticals Ltd.
Emcure Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Emcure Pharmaceuticals Ltd. engages in developing, manufacturing and marketing of pharmaceutical products. Its products include Nucron, Xennea, Xennex, Nifirex, Criante and Oncocare. The company offers calcium channel blockers, beta blockers, hypotensive combinations, statins, anti-coagulants, and diuretic combinations for cardiology. Its product portfolio includes orals, injectable and biologics, as well as an mRNA platform through which it is developing a COVID-19 vaccine. The company was founded by Satish Ramanlal Mehta on April 16, 1981 and is headquartered in Pune, India. | Corporate Officer/Principal | 01/04/1989 |
Formazione di Sanjay Rajanikant Mehta
| University of Pune | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 2 |
|---|---|
Zuventus Healthcare Ltd.
Zuventus Healthcare Ltd. Pharmaceuticals: MajorHealth Technology Zuventus Healthcare Ltd operates as pharmaceutical company. The company was founded in 15th July, 2002 and is headquartered in Mumbai, India. | Health Technology |
Emcure Pharmaceuticals Ltd.
Emcure Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Emcure Pharmaceuticals Ltd. engages in developing, manufacturing and marketing of pharmaceutical products. Its products include Nucron, Xennea, Xennex, Nifirex, Criante and Oncocare. The company offers calcium channel blockers, beta blockers, hypotensive combinations, statins, anti-coagulants, and diuretic combinations for cardiology. Its product portfolio includes orals, injectable and biologics, as well as an mRNA platform through which it is developing a COVID-19 vaccine. The company was founded by Satish Ramanlal Mehta on April 16, 1981 and is headquartered in Pune, India. | Health Technology |
- Borsa valori
- Insiders
- Sanjay Rajanikant Mehta